Showing results (101-110 of 651) with videos related to
Sort By:
Pageof 66
Journal of Cancer|October 13, 2018
Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasisMiho Kono, Takeo Fujii, Naoko Matsuda, et al.Journal of the American Medical Informatics Association : JAMIA|April 17, 2014
Attitudes regarding privacy of genomic information in personalized cancer therapyDeevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, et al.Human Pathology|July 28, 2019
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological featuresQingqing Ding, Hui Chen, Bora Lim, et al.Oncotarget|May 15, 2015
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?Fanny Le Du, Bedrich L Eckhardt, Bora Lim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2024
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 PatientsFunda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Determinants of rapamycin sensitivity in breast cancer cellsWoo-Chul Noh, Wallace H Mondesire, Junying Peng, et al.Oncotarget|September 7, 2019
TAK228 enhances antitumor activity of eribulin in triple negative breast cancerNicci Owusu-Brackett, Kurt W Evans, Argun Akcakanat, et al.Cancer|July 30, 2011
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancerSoley Bayraktar, Leonel F Hernadez-Aya, Xiudong Lei, et al.JCO Clinical Cancer Informatics|September 25, 2019
Operationalization of Next-Generation Sequencing and Decision Support for Precision OncologyJia Zeng, Amber Johnson, Md Abu Shufean, et al.Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.Pageof 66